Sector consensus Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.550 USD | +16.78% |
|
+16.39% | +29.09% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 12.93 | +264.32% | 15 | ||||||
| 665.48 | +23.33% | 23 | ||||||
| 191.05 | -0.82% | 21 | ||||||
| 225.47 | +16.66% | 19 | ||||||
| 412.35 | +42.19% | 27 | ||||||
| 254,025.79 | +41.76% | 24 | ||||||
| 255.9 | +10.83% | 18 | ||||||
| 443.5 | -17.06% | 12 | ||||||
| 71.03 | +4.18% | 14 | ||||||
| 105.91 | +31.26% | 23 | ||||||
| 175.31 | +1.34% | 16 | ||||||
| 68 | -4.09% | 12 | ||||||
| 215.33 | -4.54% | 15 | ||||||
| 66.53 | +14.1% | 15 | ||||||
| 130.53 | -1.57% | 12 | ||||||
| 49.44 | -5.89% | 16 | ||||||
| 619.78 | +76.8% | 18 | ||||||
| 123.05 | +12.56% | 21 | ||||||
| 43.96 | +10.49% | 14 | ||||||
| 45.76 | +18.84% | 17 | ||||||
| Average | 12,897.36 | +26.73% | 18 | ||||||
| Weighted average by Cap. | 19,572.62 | +16.73% | 19 |
- Stock Market
- Stocks
- CATX Stock
- Sector Perspective Therapeutics, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
